The global Janus Kinase 3 (JAK3) Inhibitor Market is poised for substantial expansion, driven by the emergence of highly targeted oral therapies for a wide spectrum of chronic autoimmune and inflammatory diseases. As a critical component of the JAK-STAT signaling pathway, JAK3 inhibition offers a powerful mechanism to modulate immune responses, particularly in conditions where current... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/